In acute phase and in the CCC, IL-6 has long been recognized as a mediator of inflammatory cardiomyopathy, as well as, a promoter of endothelial dysfunction and myocardial fibrosis, which culminate in HF (Sunnemark et al., 1996; Diaz et al., 2009). This evidence concerns the gene IL6 and endothelial dysfunction.